Clinical Microbiology and Infection

Papers
(The H4-Index of Clinical Microbiology and Infection is 76. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-08-01 to 2024-08-01.)
ArticleCitations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis1038
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review605
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study587
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis540
Follow-up of adults with noncritical COVID-19 two months after symptom onset503
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting478
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study478
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society 403
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults293
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis292
Novel SARS-CoV-2 variants: the pandemics within the pandemic281
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis266
Female gender is associated with long COVID syndrome: a prospective cohort study265
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel254
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors232
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study230
Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis220
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain217
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients210
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients205
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres202
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis195
Viable SARS-CoV-2 in various specimens from COVID-19 patients181
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study171
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital160
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection149
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study145
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline140
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis139
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection137
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity136
2020 list of human papillomavirus assays suitable for primary cervical cancer screening135
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review133
Validation of a commercially available SARS-CoV-2 serological immunoassay129
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results128
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology127
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1126
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico122
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)122
Post–COVID-19 chronic symptoms: a postinfectious entity?118
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs117
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit117
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review113
Anosmia in COVID-19 patients111
ESCMID COVID-19 living guidelines: drug treatment and clinical management108
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study107
Ibuprofen use and clinical outcomes in COVID-19 patients105
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients102
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients102
How to interpret and use COVID-19 serology and immunology tests101
Understanding the role of bacterial and fungal infection in COVID-19101
The interface between COVID-19 and bacterial healthcare-associated infections99
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities99
Stigma at the time of the COVID-19 pandemic98
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review98
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan97
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort95
How do I manage nocardiosis?95
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection95
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study94
Risk factors for chronic biofilm-related infection associated with implanted medical devices94
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status93
Commercially available molecular tests for human papillomaviruses: a global overview93
Pulmonary long-term consequences of COVID-19 infections after hospital discharge91
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study91
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study90
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study90
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients88
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis87
Evolution of viral quasispecies during SARS-CoV-2 infection87
Neurologic manifestations associated with COVID-19: a multicentre registry87
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review86
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort85
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy83
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns79
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?77
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis76
Review of trials currently testing treatment and prevention of COVID-1976
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)76
0.0973219871521